Vax-Immune Diagnostics, LLC

Vax-ImmuneTM attended the FUND Conference held in Austin, Texas, on April 26 as an invited participant.  Vax-Immune was a top ten finalist at this national event. Over 100 companies introduced their products to an educated audience of investors.

Vax-Immune is one of twenty-three medical device startup companies that kicked off its four-month residency at the TMC Innovation Institute's Opening Event on August 6, 2018.

Vax-Immune™ will travel to China to showcase LabReady® as part of the award

Vax-immune receives notice of allowance for "Portable Disposable Re-usable Culture Device for Rapid Diagnosis of Infectious Agents"

Contact: Leonard E. Weisman, President & CTO Tel:  713.662.0077 Cell: 832.423.0055 Email: lweisman@vaximmune.com Website: http://www.vaximmune.com Vax-Immune Presents its LabReady® Device at the 2017 Texas Life Science Forum FOR IMMEDIATE...

Vax-Immune, LLC competed in the fifth annual MedTech Pediatric Innovation Showcase in Washington, D.C. as one of only eight finalists selected from businesses around the world.

Vax-Immune, LLC was one of sixteen veteran-owned businesses from across the country that was selected to compete in the third annual EO-Houston Veterans Business Battle.

Vax-Immune, LLC is pleased to announce it has begun operating a laboratory located at JLABS at the Texas Medical Center (JLABS @ TMC)

New patent paves the way for Vax-Immune to create a new standard of care in preventing and diagnosing infections.

The Consortium for Technology and Innovation in Pediatrics, a Device Accelerator Run by Children’s Hospital Los Angeles, is pleased to be working with Vax-Immune.